Reply: Survive the Threat of Slow VT

Free article

Comment

Ángel Arenal et al. J Am Coll Cardiol. 2022.

Free article

. 2022 Sep 6;80(10):e79-e80.

doi: 10.1016/j.jacc.2022.06.024.

No abstract available

Comment on

Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
Arenal Á, Ávila P, Jiménez-Candil J, Tercedor L, Calvo D, Arribas F, Fernández-Portales J, Merino JL, Hernández-Madrid A, Fernández-Avilés FJ, Berruezo A. Arenal Á, et al. J Am Coll Cardiol. 2022 Apr 19;79(15):1441-1453. doi: 10.1016/j.jacc.2022.01.050. J Am Coll Cardiol. 2022. PMID: 35422240 Clinical Trial.
Slow Ventricular Tachycardia on Amiodarone: An Adverse Complication or an Efficacy Outcome.
Reiffel JA. Reiffel JA. J Am Coll Cardiol. 2022 Sep 6;80(10):e75. doi: 10.1016/j.jacc.2022.05.056. J Am Coll Cardiol. 2022. PMID: 36049809 No abstract available.
Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardias: Is the Debate Over?
Benali K, Martins RP, Guenancia C, Da Costa A, de Chillou C. Benali K, et al. J Am Coll Cardiol. 2022 Sep 6;80(10):e77. doi: 10.1016/j.jacc.2022.05.057. J Am Coll Cardiol. 2022. PMID: 36049810 No abstract available.